Arsenic Trioxide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01169 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | unclassified myelodysplastic syndrome | KG + DL |
| 2 | refractory cytopenia of childhood | KG + DL |
| 3 | severe congenital hypochromic anemia with ringed sideroblasts | KG + DL |
| 4 | aregenerative anemia | KG + DL |
| 5 | partial deletion of the long arm of chromosome 5 | KG + DL |
| 6 | myelodysplastic syndrome | KG + DL |
| 7 | Ewing sarcoma | KG + DL |
| 8 | dermatofibrosarcoma protuberans | KG + DL |
| 9 | liposarcoma | KG + DL |
| 10 | ovarian myxoid liposarcoma | KG + DL |
| 11 | uterine corpus sarcoma | KG + DL |
| 12 | acute myeloid leukemia with t(8;21)(q22;q22) translocation | KG + DL |
| 13 | osteoarthritis | KG + DL |
| 14 | acute myeloid leukemia with CEBPA somatic mutations | KG + DL |
| 15 | acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | KG + DL |
| 16 | botryoid-type embryonal rhabdomyosarcoma of the vagina | KG + DL |
| 17 | parameningeal embryonal rhabdomyosarcoma | KG + DL |
| 18 | osteoarthritis susceptibility | KG + DL |
| 19 | extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 20 | embryonal extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 21 | prostate embryonal rhabdomyosarcoma | KG + DL |
| 22 | bulbar polio | KG + DL |
| 23 | monocytic leukemia | KG + DL |
| 24 | rhabdomyosarcoma (disease) | KG + DL |
| 25 | bone sarcoma | KG + DL |
| 26 | liver sarcoma | KG + DL |
| 27 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 28 | 5q35 microduplication syndrome | KG + DL |
| 29 | pseudoachondroplasia | KG + DL |
| 30 | fibroblastic neoplasm | KG + DL |
| 31 | kidney fibrosarcoma | KG + DL |
| 32 | conventional fibrosarcoma | KG + DL |
| 33 | heart fibrosarcoma | KG + DL |
| 34 | low grade fibromyxoid sarcoma | KG + DL |
| 35 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 36 | brachyolmia | KG + DL |
| 37 | myosclerosis | KG + DL |
| 38 | chronic myelogenous leukemia, BCR-ABL1 positive | KG + DL |
| 39 | lissencephaly spectrum disorders | KG + DL |
| 40 | vulva sarcoma | KG + DL |
| 41 | giant cell tumor of soft tissue | KG + DL |
| 42 | neuralgic amyotrophy | KG + DL |
| 43 | sarcoma, avian | KG + DL |
| 44 | amyotrophic neuralgia | KG + DL |
| 45 | inherited acute myeloid leukemia | KG + DL |
| 46 | orbit sarcoma | KG + DL |
| 47 | synovial chondromatosis | KG + DL |
| 48 | upper aerodigestive tract neoplasm | KG + DL |
| 49 | Fanconi anemia | KG + DL |
| 50 | arthropathy | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.